Comparıson of vırtual realıty-Based walkıng and treadmıll exercıse Effects on Balance and Balance… (NCT07715526) | Clinical Trial Compass
CompletedNot Applicable
Comparıson of vırtual realıty-Based walkıng and treadmıll exercıse Effects on Balance and Balance ın Chronic Stroke
Turkey (Türkiye)26 participantsStarted 2026-03-15
Plain-language summary
The aim of this study is to compare the effects of virtual reality-based walking exercises and treadmill walking exercises on balance, fear of falling, motor function, respiratory function, and fatigue in individuals who have had a stroke.
The main questions it aims to answer are:
How do virtual reality-based gait exercises and treadmill exercises affect balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke? H0: There is no statistically significant difference between virtual reality-based gait exercises and treadmill exercises in terms of their effects on balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke.
H1: There is a statistically significant difference between virtual reality-based gait exercises and treadmill exercises in terms of their effects on balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Chronic stroke patients with hemiparesis (stroke \>6 months post-stroke).
* Ages 18-75.
* No visual, auditory, or communication problems.
* No additional neurological, cardiovascular, orthopedic, etc. conditions causing balance problems. Mini-Mental State Assessment (MMSE) score ≥24
* Functional Ambulation Classification (FAS) level 4-5
* Impaired pulmonary function (FEV1/FVC \<70% with spirometry)
* Providing informed consent and being a volunteer
* Speaking and understanding Turkish.
Exclusion Criteria:
* Peripheral occlusive arterial disease
* Uncontrolled hypertension (≥190/110 mmHg)
* History of epilepsy
* Inability to respond to visual and sensory stimuli
* Orthopedic problems restricting movement in the lower extremities
* Having undergone any botulinum toxin application or surgery within the last 6 months
* Having neglect syndrome or speech disorders
* Vestibular system problems or use of medications that may affect the vestibular system
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Respiratory Outcome Measures - Volume (L)
Timeframe: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
2
Respiratory Outcome Measures - Ratio (%)
Timeframe: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
3
Respiratory Outcome Measures - Flow Rate (L/min)
Timeframe: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
4
Respiratory Outcome Measures - Flow Rate (L/s)
Timeframe: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
5
Respiratory Outcome Measures - Pressure (cmH₂O)
Timeframe: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT